← Open Payments lookup

NAZAR AL-SAIDI: Open Payments

NPI 1831158153 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,483 in 247 payments from 18 companies in 2025. Trend: 2023 $1,742 · 2024 $2,599 · 2025 $3,483

Food & beverage: $3,483
CompanyPaymentsAmount
ABBVIE INC.44$607
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)34$513
Vanda Pharmaceuticals Inc.23$329
Otsuka America Pharmaceutical, Inc.23$308
Teva Pharmaceuticals USA, Inc.30$278
Axsome Therapeutics, Inc.13$269
Lundbeck LLC15$231
E.R. Squibb & Sons, L.L.C.20$230
Supernus Pharmaceuticals, Inc.18$211
Neurocrine BioSciences, Inc.5$96

Products named: VRAYLAR, CAPLYTA, REXULTI, FANAPT, COBENFY, Auvelity, Qelbree, AUSTEDO XR.

Industry payments across MI — which companies pay providers there.